• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不良作用背后的分子事件。

Molecular Events Behind Adverse Effects.

机构信息

Department of Immunology and Microbiology, Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.

Research Center of Translational Medicine, Shanghai Children's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.

出版信息

Adv Exp Med Biol. 2020;1248:119-141. doi: 10.1007/978-981-15-3266-5_6.

DOI:10.1007/978-981-15-3266-5_6
PMID:32185709
Abstract

Immune checkpoint blockade (ICB) therapy has become a promising way of overcoming cancers, whereas the therapy can induce immunopathology due to the disruption of the immune homeostasis. These adverse events caused by ICB are named as immune-related adverse events (irAEs), which can be severe and life-threaten. Understanding the mechanisms and managements of irAEs is critical for improving the efficacy of immune checkpoint therapy. Immune-related adverse events can occur on various organs, and gastrointestinal tract has the highest rate for severe irAEs. Accumulated evidences indicate the ability of the gut microbiota in regulating the response to immune checkpoint therapy, but the function of microbiota in irAEs remains unclear. T cells, including functional subsets: Th17 T cells and regulatory T (Treg) cells, play significant roles in determining the inflammatory microenvironment. The gut immune tolerance toward dietary antigens and commensals, and anti-inflammatory function in intestines are maintained mainly by Treg cells. Furthermore, tissue residency of functional T cells depends on the homing/trafficking to the locations of inflammation. Here, we review the role of microbiota and the interaction between microbiota and intestinal Treg cells in irAEs, and discuss the function of gut-trafficking blockade antibodies in the context of ICB therapy.

摘要

免疫检查点阻断(ICB)疗法已成为克服癌症的一种有前途的方法,然而,由于免疫稳态的破坏,该疗法可引发免疫病理学。这些由 ICB 引起的不良事件被命名为免疫相关不良事件(irAEs),它们可能很严重且危及生命。了解 irAEs 的机制和管理对于提高免疫检查点治疗的疗效至关重要。irAEs 可发生在各种器官上,而胃肠道发生严重 irAEs 的几率最高。大量证据表明肠道微生物群在调节对免疫检查点治疗的反应方面具有能力,但微生物群在 irAEs 中的功能仍不清楚。T 细胞,包括功能亚群:Th17 T 细胞和调节性 T(Treg)细胞,在决定炎症微环境方面发挥着重要作用。肠道对膳食抗原和共生菌的免疫耐受以及肠道的抗炎功能主要由 Treg 细胞维持。此外,功能性 T 细胞的组织驻留取决于向炎症部位的归巢/迁移。在这里,我们综述了微生物群的作用以及微生物群与肠道 Treg 细胞之间的相互作用在 irAEs 中的作用,并讨论了肠道贩运阻断抗体在 ICB 治疗中的作用。

相似文献

1
Molecular Events Behind Adverse Effects.不良作用背后的分子事件。
Adv Exp Med Biol. 2020;1248:119-141. doi: 10.1007/978-981-15-3266-5_6.
2
Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis.癌症免疫疗法中的检查点抑制剂可能会由于 Treg 稳态的丧失而导致自身免疫性不良反应。
Semin Cancer Biol. 2020 Aug;64:29-35. doi: 10.1016/j.semcancer.2019.01.006. Epub 2019 Feb 1.
3
Therapeutic Development of Immune Checkpoint Inhibitors.免疫检查点抑制剂的治疗开发。
Adv Exp Med Biol. 2020;1248:619-649. doi: 10.1007/978-981-15-3266-5_23.
4
alters the gut microbiota and modulates the functional metabolism of T regulatory cells in the context of immune checkpoint blockade.改变肠道微生物群,并在免疫检查点阻断的情况下调节 T 调节细胞的功能代谢。
Proc Natl Acad Sci U S A. 2020 Nov 3;117(44):27509-27515. doi: 10.1073/pnas.1921223117. Epub 2020 Oct 19.
5
Immune checkpoint blockade toxicity among patients with cancer presenting to the emergency department.癌症患者急诊就诊时免疫检查点阻断毒性。
Emerg Med J. 2019 May;36(5):306-309. doi: 10.1136/emermed-2018-208091. Epub 2019 Mar 25.
6
Understanding adverse events of immunotherapy: A mechanistic perspective.理解免疫治疗的不良反应:一种机制观点。
J Exp Med. 2021 Jan 4;218(1). doi: 10.1084/jem.20192179.
7
Intestinal microbiota: A potential target for enhancing the antitumor efficacy and reducing the toxicity of immune checkpoint inhibitors.肠道微生物群:增强免疫检查点抑制剂抗肿瘤疗效并降低其毒性的潜在靶点。
Cancer Lett. 2021 Jul 1;509:53-62. doi: 10.1016/j.canlet.2021.04.001. Epub 2021 Apr 14.
8
Role of B cells in immune-related adverse events following checkpoint blockade.B 细胞在检查点阻断后免疫相关不良事件中的作用。
Immunol Rev. 2023 Sep;318(1):89-95. doi: 10.1111/imr.13238. Epub 2023 Jul 8.
9
Mechanisms underlying immune-related adverse events during checkpoint immunotherapy.免疫检查点治疗相关免疫不良反应的发生机制。
Clin Sci (Lond). 2022 May 27;136(10):771-785. doi: 10.1042/CS20210042.
10
The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.炎症、营养供应和共生微生物群在肠道病原体感染中的作用。
Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014.

引用本文的文献

1
Biomarkers associated with immune-related adverse events induced by immune checkpoint inhibitors.与免疫检查点抑制剂诱导的免疫相关不良事件相关的生物标志物。
World J Clin Oncol. 2024 Aug 24;15(8):1002-1020. doi: 10.5306/wjco.v15.i8.1002.